Delivery Order SPE2DB20D1110-SPE2DB25FK37Z
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,867.20 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of August 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The pharmaceutical distributor will perform this delivery order from its corporate office location...
- The Defense Logistics Agency (DLA) awarded a $1,366.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of July 14, 2025. This non-set-aside competitively awarded contract is classified as a child delivery order, indicating it derives from a larger indefinite delivery vehicle. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,727.04 on August 21, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units. This competitively awarded, firm fixed-price delivery order is a child contract with an ultimate completion date of August 22, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, allowing AmerisourceBergen to compete openly for this...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s with a ceiling value of $5,742.45. This competitively awarded, non-set-aside contract was executed on September 9, 2025, with an ultimate completion date of September 10, 2025, and reflects a firm fixed price arrangement. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Lidocaine 5% patches (30-count) with a ceiling value of $120,742.35. This firm fixed-price delivery order, which is expected to be completed by September 2, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX. The award was competitively awarded with no set-aside provisions....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Lidocaine 5% Patch 30s with a ceiling value of $8,028.28. This competitively awarded, non-set-aside order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The delivery order carries a firm fixed price structure with an ultimate completion date...
- The Defense Logistics Agency (DLA) awarded a $1,963.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of June 11, 2025. This non-set-aside competitive award was issued on June 10, 2025, with performance to be conducted at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's substantial $999.99 billion Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,297.25 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Lidocaine 5% Patch 30s. This competitively awarded contract, utilizing firm fixed pricing with no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for Lidocaine 5% Patch 30-count units with a ceiling value of $3,936.42. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of June 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Lidocaine 5% Patch (30-count units) under a firm fixed-price arrangement with a ceiling value of $1,412.04. The contract, which is not set-aside and was competitively awarded, represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This underlying prime IDV, designated SPE2DX and valued at...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK37ZDelivery Order
The Defense Logistics Agency (DLA) awarded a $7,010.69 delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch (30 count) with an ultimate completion date of September 4, 2025. This non-set-aside contract was competitively awarded on a firm fixed price basis and represents a child delivery order under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order falls under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a critical pharmaceutical distributor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems and other government customers. The Lidocaine patch delivery fulfills pain management pharmaceutical needs within the DLA's broader medical supply chain supporting Defense Health Agency operations and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 9/3/25 |